How autophagy controls the intestinal epithelial barrier

EG Foerster, T Mukherjee, L Cabral-Fernandes… - Autophagy, 2022 - Taylor & Francis
Macroautophagy/autophagy is a cellular catabolic process that results in lysosome-
mediated recycling of organelles and protein aggregates, as well as the destruction of …

IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

B Verstockt, A Salas, BE Sands, C Abraham… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-12 (IL-12) and interleukin-23 (IL-23), which belong to the IL-12 family of
cytokines, have a key role in intestinal homeostasis and inflammation and are implicated in …

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Z Liu, R Liu, H Gao, S Jung, X Gao, R Sun, X Liu… - Nature …, 2023 - nature.com
Inflammatory bowel diseases (IBDs) are chronic disorders of the gastrointestinal tract with
the following two subtypes: Crohn's disease (CD) and ulcerative colitis (UC). To date, most …

Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis

Z Zhong, G Su, A Kijlstra, P Yang - Progress in retinal and eye research, 2021 - Elsevier
Uveitis is a group of diseases characterized by intraocular inflammation, of which some are
driven by autoinflammatory or autoimmune responses, such as Vogt-Koyanagi-Harada …

Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases

EL Barnes, EV Loftus Jr, MD Kappelman - Gastroenterology, 2021 - Elsevier
Although Crohn's disease (CD) and ulcerative colitis (UC) have been considered as
disorders that affect individuals of European ancestry, the epidemiology of the inflammatory …

[HTML][HTML] Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease

L Duan, S Cheng, L Li, Y Liu, D Wang… - Frontiers in …, 2021 - frontiersin.org
Inflammatory bowel disease (IBD) represents chronic recurrent intestinal inflammation
resulting from various factors. Crohn's disease (CD) and ulcerative colitis (UC) have been …

Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome

LS Celiberto, FA Graef, GR Healey, ES Bosman… - …, 2018 - Wiley Online Library
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal
tract, thought to at least in part reflect an aberrant immune response to gut bacteria. IBD is …

Translating immunology into therapeutic concepts for inflammatory bowel disease

HH Uhlig, F Powrie - Annual review of immunology, 2018 - annualreviews.org
Inflammatory bowel disease (IBD) defines a spectrum of complex disorders. Understanding
how environmental risk factors, alterations of the intestinal microbiota, and polygenetic and …

New insights into the IL-12 and IL-23: From a molecular basis to clinical application in immune-mediated inflammation and cancers

IT Chyuan, JH Lai - Biochemical pharmacology, 2020 - Elsevier
Abstract The cytokines interleukin-12 (IL-12) and IL-23 share a common IL-12/IL-23p40
subunit in structure and play a central role in T cell-mediated responses in inflammation …

Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort

K Gettler, R Levantovsky, A Moscati, M Giri, Y Wu… - Gastroenterology, 2021 - Elsevier
Background and Aims Polygenic risk scores (PRS) may soon be used to predict
inflammatory bowel disease (IBD) risk in prevention efforts. We leveraged exome-sequence …